News >

Ruxolitinib Combos Explored to Address MPN-Associated Symptoms

Brandon Scalea
Published: Monday, May 06, 2019

Laura Michaelis, MD

Laura Michaelis, MD

One of the biggest challenges in patients with myeloproliferative neoplasms (MPNs) is managing associated symptoms, but a myriad of ongoing studies evaluating ruxolitinib (Jakafi) in combination are hoping to address this, said Laura Michaelis, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Publication Bottom Border
Border Publication